Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2058354

Cover Image

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2058354

HbA1c Testing Device Market, By Product Type, By Technology, By End User, By Geography

PUBLISHED:
PAGES: 152 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4500
PDF & Excel (Multi User License - Up to 7 Users)
USD 7000
PDF & Excel (Corporate User License)
USD 10000

Add to Cart

HbA1c Testing Device Market is estimated to be valued at USD 2.45 Bn in 2026 and is expected to reach USD 3.78 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7.7% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 2.45 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 7.70% 2033 Value Projection: USD 3.78 Bn

The HbA1c testing devices are indispensable in diagnosing and managing diabetes on an ongoing basis because they determine the mean concentration of sugar in the bloodstream over the duration of two to three months. The increasing prevalence of diabetes globally and especially among the elderly, as well as in urban populations, is the key factor promoting the need for HbA1c testing solutions.

In terms of applications, HbA1c testing instruments are widely utilized within hospitals, diagnostics labs, physicians' clinics, as well as in-home healthcare facilities where patients' mean concentrations of blood glucose need to be monitored on a regular basis. Such an effective solution helps improve patient care through timely medical decision making and individual treatment approaches. The use of point-of-care testing devices also contributes to market growth. Moreover, technological innovations in immunoassay analyzer systems, boronate affinity chromatography, and high-performance liquid chromatography (HPLC), together with compact, easy-to-use instruments, are shaping the future of testing. Awareness about preventive healthcare, increased accessibility of diagnostic testing facilities in developing countries, and the increasing popularity of decentralized testing are some of the factors driving growth in the global market for HbA1c testing devices.

Market Dynamics

The HbA1c testing device market is propelled by growing incidence of diabetes and prediabetes around the world, and the need for efficient glycemic control over the long term. Growing awareness about the importance of early diagnosis and treatment of diseases, as well as the increasing tendency towards preventive medicine, greatly increases the demand for HbA1c testing devices. In addition, the demand for testing devices is stimulated by the increasing preference of modern patients for fast and efficient point-of-care tests. Technological innovations, including the appearance of automated analyzers and portable testing devices, as well as their integration into health information technology platforms, also positively affects the demand for testing devices.

Nonetheless, there are certain market limitations, such as expensive diagnostic equipment and inadequate health care facilities in less developed and developing nations. Differences in precision due to hemoglobin abnormalities and some health conditions could affect the efficiency of the process, which could be another limitation of this market. In addition, improper reimbursement policies in some nations and insufficiently skilled personnel to operate the highly sophisticated diagnostic tools could further hamper the market's growth. On the other hand, many opportunities will arise in this market during the forecast period, including the rising trend of decentralized testing, development of healthcare facilities in developing nations, and innovation in HbA1c diagnostic tests.

Key Features of the Study

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global HbA1c testing device market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Abbott Laboratories, F. Hoffmann-La Roche Ltd., Siemens Healthineers, Danaher Corporation, Bio-Rad Laboratories, ARKRAY Inc., Trinity Biotech plc, EKF Diagnostics Holdings plc, A. Menarini Diagnostics, and Tosoh Corporation
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global HbA1c testing device market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global HbA1c testing device market

Market Segmentation

  • Product Type Insights (Revenue, USD Bn, 2021 - 2033)
    • Point-of-Care (POC) Testing Devices
    • Laboratory-based Analyzers
  • Technology Insights (Revenue, USD Bn, 2021 - 2033)
    • Immunoassay
    • Enzymatic Assay
    • Chromatography
    • Others
  • End User Insights (Revenue, USD Bn, 2021 - 2033)
    • Hospitals
    • Diagnostic Laboratories
    • Clinics
    • Homecare Settings
    • Others
  • Regional Insights (Revenue, USD Bn, 2021 - 2033)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Abbott Laboratories
    • Hoffmann-La Roche Ltd.
    • Siemens Healthineers
    • Danaher Corporation
    • Bio-Rad Laboratories
    • ARKRAY Inc.
    • Trinity Biotech plc
    • EKF Diagnostics Holdings plc
    • Menarini Diagnostics
    • Tosoh Corporation
Product Code: CMI9465

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global HbA1c Testing Device Market, By Product Type
    • Global HbA1c Testing Device Market, By Technology
    • Global HbA1c Testing Device Market, By End User
    • Global HbA1c Testing Device Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Market Opportunities
  • Regulatory Scenario
  • Key Developments
  • Industry Trends

4. Global HbA1c Testing Device Market, By Product Type, 2021-2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Point-of-Care (POC) Testing Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Laboratory-based Analyzers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. Global HbA1c Testing Device Market, By Technology, 2021-2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Immunoassay
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Enzymatic Assay
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Chromatography
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global HbA1c Testing Device Market, By End User, 2021-2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Hospitals and Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Diagnostic Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Homecare Settings
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

7. Global HbA1c Testing Device Market, By Region, 2021 - 2033, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

8. Competitive Landscape

  • Abbott Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Hoffmann-La Roche Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Siemens Healthineers
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Danaher Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bio-Rad Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • ARKRAY Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Trinity Biotech plc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • EKF Diagnostics Holdings plc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Menarini Diagnostics
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Tosoh Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

9. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

10. References and Research Methodology

  • References
  • Research Methodology
  • About us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!